Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.96
Price to sales ratio
0.3
Dividends per share
0.34
Dividend yield %
4.74

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1324
ORKA
Oruka Therapeutics, Inc. - Common Stock
84.56 USD-2.57%+1.76%+21.27%+163.67%5.10 B USD
1392
MANE
Veradermics, Incorporated Common Stock
110.00 USD-7.99%-12.07%+13.50%+233.33%4.60 B USD
1752
MBX
MBX Biosciences, Inc. - Common Stock
60.04 USD-1.65%+3.36%+67.71%+327.03%2.86 B USD
1954
PVLA
Palvella Therapeutics, Inc. - Common Stock
146.03 USD+0.88%+3.30%+30.28%+97.74%2.09 B USD

Frequently asked questions about Organon & Co. Common Stock

What is the Organon & Co. Common Stock stock price today?

The current price of Organon & Co. Common Stock (OGN) is 13.51. Over the past 24 hours, the stock has changed by -0.15%. Follow the OGN chart for real-time price dynamics.

What is the stock ticker of Organon & Co. Common Stock?

Organon & Co. Common Stock trades under the ticker OGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Organon & Co. Common Stock stock going up?

OGN has changed by -0.37% over the last week, +0.52% over the last month, and +86.09% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Organon & Co. Common Stock release financial reports?

Yes. You can track Organon & Co. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Organon & Co. Common Stock net income for the last quarter?

Organon & Co. Common Stock reported net income of 146 M for the last quarter. The previous quarter showed -205 M, which means net income changed by +171.22%.

How many employees does Organon & Co. Common Stock have?

As of the latest available data, Organon & Co. Common Stock has 10 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Organon & Co. Common Stock EBITDA?

Organon & Co. Common Stock EBITDA is 402 M, and its EBITDA margin is 27.53%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Organon & Co. Common Stock stock?

You can buy Organon & Co. Common Stock (OGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Organon & Co. Common Stock stock?

Investing in Organon & Co. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OGN chart and related analysis on metatrader.com as part of your research.

Organon & Co. Common Stock

Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

News